"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox Patt tells PEOPLE ...
Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could roil a multibillion-dollar market.
Morning Overview on MSN
FDA approves J&J’s once-daily Icotyde pill for plaque psoriasis
Johnson & Johnson said the FDA approved Icotyde (icotrokinra), a once-daily oral treatment for adults with moderate to severe ...
—Immune checkpoint molecular upregulation is linked with chronicity and severity of chronic plaque psoriasis, whereas downregulation is linked with poor prognosis of guttate psoriasis. Reviewed by ...
About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...
Protagonist Therapeutics recently received U.S. FDA approval for ICOTYDE (icotrokinra) to treat adults with moderate to severe plaque psoriasis, and held a special call on March 18, 2026 to discuss ...
Many people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin. But some people with moderate or severe plaque psoriasis have symptoms that do ...
Working on fast cars has been Rogelio "Al" Castro's lifelong passion. Now, in retirement, he loves to take his grandkids to the speedway and tell them what it was like when he worked in the pit - the ...
Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results